Literature DB >> 11224661

Metabolic changes after cardiac surgery.

S M Jakob1, H Ensinger, J Takala.   

Abstract

The metabolic changes that occur after cardiac surgery result from a complex interaction between the effects of surgery and extracorporeal circulation per se, the inflammatory response to surgical trauma and extracorporeal circulation, perioperative use of hypothermia, the cardiovascular and neuroendocrine responses characteristic to cardiac surgery, and the drugs and blood products used to support circulation during and after operation. These changes include among others increased oxygen consumption and energy expenditure and increased secretion of insulin, growth hormone, adrenocorticotrophic hormone, cortisol, epinephrine and norepinephrine. Other changes include decreased total-Trijodthyronine levels, hyperglycemia, hyperlactatemia, increased glutamate, aspartate and free fatty acid concentrations, hypokalemia, an increased production of inflammatory cytokines and increased consumption of complement and adhesion molecules. There is evidence that better control of metabolic abnormalities improves the patients' outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11224661     DOI: 10.1097/00075197-200103000-00012

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  8 in total

1.  Resting energy expenditure after Fontan surgery in children with single-ventricle heart defects.

Authors:  Nilesh M Mehta; John M Costello; Lori J Bechard; Victor M Johnson; David Zurakowski; Francis X McGowan; Peter C Laussen; Christopher P Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-04-26       Impact factor: 4.016

Review 2.  Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Postoperative cognitive dysfunction is correlated with urine formaldehyde in elderly noncardiac surgical patients.

Authors:  Jiawan Wang; Tao Su; Ying Liu; Yun Yue; Rongqiao He
Journal:  Neurochem Res       Date:  2012-08-07       Impact factor: 3.996

4.  Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.

Authors:  Paul G Davies; Balasubramanian Venkatesh; Thomas J Morgan; Jeffrey J Presneill; Peter S Kruger; Bronwyn J Thomas; Michael S Roberts; Julie Mundy
Journal:  Crit Care       Date:  2011-01-14       Impact factor: 9.097

5.  Adverse Outcomes in Obese Cardiac Surgery Patients Correlates With Altered Branched-Chain Amino Acid Catabolism in Adipose Tissue and Heart.

Authors:  Dipsikha Biswas; Kathleen Tozer; Khoi T Dao; Lester J Perez; Angella Mercer; Amy Brown; Intekhab Hossain; Alexandra M Yip; Christie Aguiar; Hany Motawea; Keith R Brunt; Jennifer Shea; Jean F Legare; Ansar Hassan; Petra C Kienesberger; Thomas Pulinilkunnil
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555

Review 6.  Nutritional Management of Patients with Fontan Circulation: A Potential for Improved Outcomes from Birth to Adulthood.

Authors:  Letizia Baldini; Katia Librandi; Chiara D'Eusebio; Antonella Lezo
Journal:  Nutrients       Date:  2022-09-29       Impact factor: 6.706

7.  Does a reduced glucose intake prevent hyperglycemia in children early after cardiac surgery? a randomized controlled crossover study.

Authors:  Carlijn T I de Betue; Sascha C A T Verbruggen; Henk Schierbeek; Shaji K Chacko; Ad J J C Bogers; Johannes B van Goudoever; Koen F M Joosten
Journal:  Crit Care       Date:  2012-10-02       Impact factor: 9.097

8.  Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.

Authors:  Michael Lehrke; Uli C Broedl; Ingeborg M Biller-Friedmann; Michael Vogeser; Volkmar Henschel; Kirsten Nassau; Burkhard Göke; Erich Kilger; Klaus G Parhofer
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.